Resultados de procura - Toppmeyer, Deborah
- Mostrando 1 - 20 Resultados de 32
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers por Bilal, Erhan, Alexe, Gabriela, Yao, Ming, Cong, Lei, Kulkarni, Atul, Ginjala, Vasudeva, Toppmeyer, Deborah, Ganesan, Shridar, Bhanot, Gyan
Publicado 2010Text -
7
Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients por Tian, Sibo, Hirshfield, Kim M., Jabbour, Salma K., Toppmeyer, Deborah, Haffty, Bruce G., Khan, Atif J., Goyal, Sharad
Publicado 2014Text -
8
A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence por Vazquez, Alexei, Kulkarni, Diptee, Grochola, Lukasz F., Bond, Gareth L., Barnard, Nicola, Toppmeyer, Deborah, Levine, Arnold J., Hirshfield, Kim M.
Publicado 2011Text -
9
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes por Mehta, Madhura S., Vazquez, Alexei, Kulkarni, Diptee A., Kerrigan, John E., Atwal, Gurinder, Metsugi, Shoichi, Toppmeyer, Deborah L., Levine, Arnold J., Hirshfield, Kim M.
Publicado 2010Text -
10
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer por Kulkarni, Diptee A., Vazquez, Alexei, Haffty, Bruce G., Bandera, Elisa V., Hu, Wenwei, Sun, Yvonne Y., Toppmeyer, Deborah L., Levine, Arnold J., Hirshfield, Kim M.
Publicado 2009Text -
11
5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial por Poppe, Matthew M., Yehia, Zeinab A., Baker, Christopher, Goyal, Sharad, Toppmeyer, Deborah, Kirstein, Laurie, Chen, Chunxia, Moore, D.F., Haffty, Bruce G., Khan, Atif J.
Publicado 2020Text -
12
Breast-Conservation Therapy after Neoadjuvant Chemotherapy Does Not Compromise 10-year Breast Cancer Specific Mortality por Arlow, Renee L, Paddock, Lisa E, Niu, Xiaoling, Kirstein, Laurie, Haffty, Bruce G, Goyal, Sharad, Kearney, Thomas, Toppmeyer, Deborah, Stroup, Antoinette M, Khan, Atif J
Publicado 2018Text -
13
Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers por Bilal, Erhan, Vassallo, Kristen, Toppmeyer, Deborah, Barnard, Nicola, Rye, Inga H., Almendro, Vanessa, Russnes, Hege, Børresen-Dale, Anne-Lise, Levine, Arnold J., Bhanot, Gyan, Ganesan, Shridar
Publicado 2012Text -
14
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial por Khan, Atif J., Poppe, Matthew M., Goyal, Sharad, Kokeny, Kristine E., Kearney, Thomas, Kirstein, Laurie, Toppmeyer, Deborah, Moore, Dirk F., Chen, Chunxia, Gaffney, David K., Haffty, Bruce G.
Publicado 2017Text -
15
Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings por Shah, Mansi R, Jan, Imraan, Johns, Jeremy, Singh, Kuldip, Kumar, Pallavi, Belarmino, Norma, Saggiomo, Kara, Hayes, Carolyn, Toppmeyer, Deborah, Washington, Kimyatta, Haffty, Bruce, Libutti, Steven, Evens, Andrew M.
Publicado 2020Text -
16
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer por Gorshein, Elan, Matsuda, Kant, Riedlinger, Gregory, Sokol, Levi, Rodriguez-Rodriguez, Lorna, Eladoumikdachi, Firas, Grandhi, Miral, Ganesan, Shridar, Toppmeyer, Deborah L., Potdevin, Lindsay, Toomey, Kathleen, Hirshfield, Kim M., Chan, Nancy
Publicado 2021Text -
17
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemother... por Rugo, Hope S., Barry, William T., Moreno-Aspitia, Alvaro, Lyss, Alan P., Cirrincione, Constance, Leung, Eleanor, Mayer, Erica L., Naughton, Michael, Toppmeyer, Deborah, Carey, Lisa A., Perez, Edith A., Hudis, Clifford, Winer, Eric P.
Publicado 2015Text -
18
SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center por Shah, Mansi R., Jan, Imraan, Johns, Jeremy, Singh, Kuldip, Kumar, Pallavi, Belarmino, Norma, Saggiomo, Kara J., Hayes, Carolyn, Washington, Kimyatta, Toppmeyer, Deborah L., Haffty, Bruce G., Libutti, Steven K., Evens, Andrew M.
Publicado 2021Text -
19
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma por Bjørklund, Sunniva Stordal, Panda, Anshuman, Kumar, Surendra, Seiler, Michael, Robinson, Doug, Gheeya, Jinesh, Yao, Ming, Alnæs, Grethe I. Grenaker, Toppmeyer, Deborah, Riis, Margit, Naume, Bjørn, Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Ganesan, Shridar, Bhanot, Gyan
Publicado 2017Text -
20
Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay por Farber-Katz, Suzette, Hsuan, Vickie, Wu, Sitao, Landrith, Tyler, Vuong, Huy, Xu, Dong, Li, Bing, Hoo, Jayne, Lam, Stephanie, Nashed, Sarah, Toppmeyer, Deborah, Gray, Phillip, Haynes, Ginger, Lu, Hsiao-Mei, Elliott, Aaron, Tippin Davis, Brigette, Karam, Rachid
Publicado 2018Text